MARC details
| 000 -LEADER |
|---|
| fixed length control field |
04342nam a22003258i 4500 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
211014s2022 dcu b 001 0 eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| ISBN |
9781615371525 |
| Qualifying information |
(paperback) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Cancelled/invalid ISBN |
9781615374007 |
| Qualifying information |
(ebook) |
| 060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
WM 402. |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal author |
Mintz, David L |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Psychodynamic psychopharmacology : |
| Subtitle |
caring for the treatment-resistant patient |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
Washington, DC : |
| Name of producer, publisher, distributor, manufacturer |
American Psychiatric Association Publishing, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2022 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Physical description |
xiii, 281p. |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
unmediated |
| Media type code |
n |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
volume |
| Carrier type code |
nc |
| Source |
rdacarrier |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - CONTENTS |
|---|
| Contents |
What Is Psychodynamic Psychopharmacology? -- Why Psychodynamic Psychopharmacology? -- What Is Psychodynamic About Psychodynamic Psychopharmacology? -- Psychodynamics of Pharmacological Treatment Resistance -- Treatment Resistance to Medications -- Treatment Resistance From Medications -- The Prescriber's Contribution to Treatment Resistance -- Avoid a Mind-Body Split -- Know Who the Patient Is -- Attend to Patients' Ambivalence -- Cultivate the Pharmacotherapeutic Alliance -- Attend to Countertherapeutic Uses of Medications -- Identify, Contain, and Use Countertransference -- Who Is Psychodynamic Psychopharmacology For? Patient Characteristics -- Before Initiating Treatment -- The Engagement Phase -- The Maintenance Phase -- Split and Combined Treatments -- Psychodynamic Psychopharmacology and Integrated Care. |
| 520 ## - ABSTRACT |
|---|
| Abstract |
"The troubling increase in treatment resistance in psychiatry has many culprits: the rise of biomedical psychiatry and corresponding sidelining of psychodynamic and psychosocial factors; the increased emphasis on treating the symptoms rather than the person; and a greater focus on the electronic medical record rather than the patient, all of which point to a breakdown in the person-centered prescriber-patient relationship. Psychodynamic Psychopharmacology illuminates a new path forward. It examines the psychological and interpersonal mechanisms of pharmacological treatment resistance, integrating research on evidence-based prescribing processes with psychodynamic insights and skills to enhance treatment outcomes for patients who are difficult to treat. The first part of the book explores the evidence base that guides how, rather than simply what, to prescribe. It describes precisely what psychodynamic psychopharmacology is and why its emphasis on combining the often-neglected psychosocial aspects of medication with biomedical considerations provides a more optimized approach to addressing treatment resistance. Part II delves into the psychodynamics that contribute to pharmacological treatment resistance, both when patients' ambivalence about their illness, the medication itself, or their prescriber manifests in nonadherence and when medications support a negative identity or are used as replacements for healthy capacities. Readers will gain basic skills for addressing the psychological and interpersonal dynamics that underpin both scenarios and will be better positioned to ameliorate interferences with the healthy use of medications. The final section of the book offers detailed technical recommendations for addressing pharmacological treatment resistance. It tackles issues that include countertransference-driven irrational prescribing; primitive dynamics, such as splitting and projective identification; and the overlap between psychopharmacological treatment resistance and the dynamics of treatment nonadherence and nonresponse in integrated and collaborative medical care settings. By putting the individual patient back at the center of the therapeutic equation, psychodynamic psychopharmacology, as outlined in this book, offers a model that moves beyond compliance and emphasizes instead the alliance between patient and prescriber. In doing so, it empowers patients to become more active contributors in their own recovery"-- |
| Assigning source |
Provided by publisher. |
| 650 12 - SUBJECT HEADINGS |
|---|
| Subject term |
Drug therapy |
| 650 12 - SUBJECT HEADINGS |
|---|
| Subject term |
Mental disorders |
| 650 22 - SUBJECT HEADINGS |
|---|
| Subject term |
Psychotropic drugs |
| 9 (RLIN) |
7615 |
| 650 22 - SUBJECT HEADINGS |
|---|
| Subject term |
Psychopharmacology |
| 650 22 - SUBJECT HEADINGS |
|---|
| Subject term |
Treatment refusal |
| 650 22 - SUBJECT HEADINGS |
|---|
| Subject term |
Physician-patient relations |
| 710 2# - ADDED CORPORATE NAME |
|---|
| Added corporate author |
American Psychiatric Association Publishing |
| Relator term |
issuing body |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Suppress in OPAC |
Do not Suppress in OPAC |
| 263 ## - PROJECTED PUBLICATION DATE |
|---|
| Projected publication date |
2203 |